↑ トップへ　← 戻る

Target Gene/Pathway（薬物標的遺伝子／パスウェイリスト）💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ, MAP2K

ABCDEFGH I JKLMNOPQRSTUVWXYZother

40 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related		 KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adipocytokine signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
2 Adipocytokine signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
3 Alanine, aspartate and glutamate metabolism 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
4 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
5 AMPK signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
6 AMPK signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
7 Apelin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
8 Apelin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
9 Autophagy - animal 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
10 Autophagy - animal 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
11 beta-Alanine metabolism 💬
 3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
12 Butanoate metabolism 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
13 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
14 cAMP signaling pathway 💬
 1件: GLP1R 💬 D04121 💬 Exenatide 4件:  6 , 17, 193, 233 💬
15 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
16 Circadian rhythm 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
17 Circadian rhythm 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
18 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
19 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
20 Fluid shear stress and atherosclerosis 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
21 Fluid shear stress and atherosclerosis 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
22 FoxO signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
23 FoxO signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
24 GABAergic synapse 💬
 3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
25 Glucagon signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
26 Glucagon signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
27 GnRH secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
28 Hypertrophic cardiomyopathy 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
29 Hypertrophic cardiomyopathy 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
30 Insulin resistance 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
31 Insulin resistance 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
32 Insulin secretion 💬
 1件: GLP1R 💬 D04121 💬 Exenatide 4件:  6 , 17, 193, 233 💬
33 Insulin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
34 Insulin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
35 Longevity regulating pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
36 Longevity regulating pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
37 Longevity regulating pathway - multiple species 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
38 Longevity regulating pathway - multiple species 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
39 MAPK signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
40 Metabolic pathways 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
41 mTOR signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
42 mTOR signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
43 Neuroactive ligand-receptor interaction 💬
 1件: GLP1R 💬 D04121 💬 Exenatide 4件:  6 , 17, 193, 233 💬
44 Non-alcoholic fatty liver disease 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
45 Non-alcoholic fatty liver disease 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
46 Oxytocin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
47 Oxytocin signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
48 PI3K-Akt signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
49 PI3K-Akt signaling pathway 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
50 Propanoate metabolism 💬
 1件: ABAT 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
51 Protein digestion and absorption 💬
 1件: DPP4 💬 D08516 💬 Sitagliptin 4件:  6 , 75, 233, 299 💬
52 Taurine and hypotaurine metabolism 💬
 2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
53 Thermogenesis 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
54 Thermogenesis 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
55 Tight junction 💬
 2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
56 Tight junction 💬
 2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
57 Type I diabetes mellitus 💬
 2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
58 Type II diabetes mellitus 💬
 1件: CACNA1G 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
59 Valine, leucine and isoleucine degradation 💬
 1件: ABAT 💬 D00399 💬 Valproic acid 16件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬

先頭へ